Sponsor study identifier
observational
59
1 country
1
Study Start
May 21, 2024
Actual (reported)Primary Completion
March 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 21, 2024
Actual (reported)July 8, 2024
Actual (reported)August 1, 2024
Actual (reported)March 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Diagnosis of fibromyalgia with the Polysymptomatic Distress Scale(PDS)
The PDS scale fibromyalgia severity (FS) scale also known as the fibromyalgia severity (FS) scale. It is the sum of the WPI and SSS, and ranges is from 0-31 with higher score indicating more severity.
up to 1 week
QOL as measured by Short Form-36 Health Status Questionnaire(SF-36)
up to 1 week
Fibromyalgia symptoms severity as measured by the Rebised Fibromyalgia Impact Questionnaire(FIQR)
up to 1 week
Depression scores as measured by Beck depression inventory(BDI)
up to 1 week
Stress scores as measured by Perceived Stress Scale(PSS)
up to 1 week
Sleep scores as measured by Pittsburgh sleep quality index(PSQI)
up to 1 week
The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
chronic widespread pain: pain on the left side of the body, pain on the right side, pain above the waist, and pain below the waist. In addition, axial bone pain (cervical or anterior chest or thoracic or lower back pain) must be present. In this definition, shoulder and hip pain are considered pain on each affected side. "Lower back pain" is thought to be lower pain.)
Guang'anmen Hospital
Beijing, Beijing Municipality, 100053, China
First Submitted
July 8, 2024
First Posted
August 1, 2024
Study Start
May 21, 2024
Actual (reported)Primary Completion
March 31, 2025
Estimated (date passed)Neurophysiology of Fibromyalgia
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 21, 2024
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: